NASDAQ:ELDN
Eledon Pharmaceuticals, Inc.
- Stock
Last Close
4.10
06/11 22:30
Market Cap
93.57M
Beta: 2.12
Volume Today
113.39K
Avg: 121.43K
PE Ratio
−0.59
PFCF: −1.06
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 440.50K - | 1.08M 146.08% | 643.50K 40.64% | ||||||||
average payables | 385K - | 986.50K 156.23% | 819K 16.98% | 424K 48.23% | 553.50K 30.54% | 509K 8.04% | 847.50K 66.50% | 1.59M 87.55% | 2.01M 26.23% | 1.58M 21.08% | |
average receivables | 122.50K - | 177.50K 44.90% | 55K 69.01% | ||||||||
book value per share | 2.59K - | 444.72 82.84% | 1.26K 184.03% | 74.85 94.07% | 28.97 61.30% | 14.44 50.15% | 131.32 809.47% | 11.07 91.57% | 5.89 46.75% | 3.39 42.50% | |
capex per share | -0.63 - | -4.07 550.25% | -0.80 80.36% | ||||||||
capex to depreciation | -1.19 - | -5.18 335.41% | -0.10 98.08% | ||||||||
capex to operating cash flow | 0.00 - | 0.01 1,057.57% | 0.00 96.60% | ||||||||
capex to revenue | |||||||||||
cash per share | 2.64K - | 460.81 82.52% | 1.29K 179.62% | 66.31 94.85% | 25.93 60.90% | 13.41 48.28% | 78.68 486.68% | 5.72 92.72% | 3.95 31.02% | 2.08 47.43% | |
days of inventory on hand | |||||||||||
days payables outstanding | 943.73 - | ||||||||||
days sales outstanding | 334.58 - | ||||||||||
debt to assets | 0.03 - | 0.00 97.54% | 0.00 517.43% | 0.01 78.30% | 0.00 62.16% | ||||||
debt to equity | 0.03 - | 0.00 97.79% | 0.00 520.65% | 0.01 88.98% | 0.00 48.19% | ||||||
dividend yield | 0.00 - | ||||||||||
earnings yield | -0.24 - | -0.23 5.87% | -11.27 4,799.74% | -0.69 93.87% | -0.98 41.34% | -2.61 167.62% | -1.02 60.93% | -0.53 48.26% | -2.69 408.84% | -0.91 66.13% | |
enterprise value | -9.90M - | 172.04M 1,838.07% | -19.85M 111.54% | 1.76M 108.86% | 1.44M 18.29% | -1.62M 212.99% | -91.70M 5,548.89% | -18.71M 79.60% | -23.09M 23.43% | 40.09M 273.59% | |
enterprise value over ebitda | 0.42 - | -3.81 1,009.53% | 0.52 113.73% | -0.13 125.66% | -0.10 23.81% | 0.13 230.81% | 6.68 4,897.03% | 0.51 92.41% | -2.60 613.12% | -0.94 63.89% | |
ev to operating cash flow | 0.47 - | -4.17 990.24% | 0.54 113.03% | -0.12 121.65% | -0.12 2.65% | 0.12 196.98% | 6.03 5,045.72% | 0.65 89.27% | 0.81 25.55% | -1.01 224.83% | |
ev to sales | -764.16 - | ||||||||||
free cash flow per share | -529.52 - | -301.18 43.12% | -1.72K 470.54% | -57.49 96.65% | -23.77 58.65% | -21.14 11.08% | -10.48 50.42% | -1.95 81.38% | -1.99 1.99% | -1.61 19.31% | |
free cash flow yield | -0.22 - | -0.21 3.86% | -10.85 4,986.93% | -0.79 92.75% | -0.83 4.92% | -2.02 145.31% | -0.68 66.39% | -0.44 34.99% | -0.87 97.26% | -0.89 2.21% | |
graham net net | 2.53K - | 415.78 83.56% | 1.15K 177.07% | 60.77 94.72% | 20.86 65.67% | 12.13 41.88% | 74.64 515.49% | 5.28 92.92% | 3.35 36.65% | 0.35 89.53% | |
graham number | 5.83K - | 1.80K 69.09% | 7.12K 295.08% | 291.55 95.91% | 135.36 53.57% | 94.13 30.46% | 215.49 128.93% | 24.08 88.83% | 28.50 18.36% | 11.17 60.79% | |
income quality | 0.91 - | 0.91 0.88% | 0.96 5.19% | 1.14 18.40% | 0.85 25.77% | 0.87 2.35% | 0.67 22.95% | 0.84 25.65% | 0.32 61.44% | 0.98 203.35% | |
intangibles to total assets | 0 - | 0 | 0 | 0.09 Infinity% | 0.11 22.71% | 0 100% | 0.41 Infinity% | 0.48 15.62% | 0.35 26.54% | 0 100% | |
interest coverage | -260.12 - | -18.39 - | |||||||||
interest debt per share | 1.25 - | 0.49 - | 0.10 79.93% | 0.05 47.70% | 0.02 61.69% | 0.02 21.75% | |||||
inventory turnover | |||||||||||
invested capital | 0.03 - | 0.00 97.79% | 0.00 520.65% | 0.01 88.98% | 0.00 48.19% | ||||||
market cap | 95.36M - | 196.06M 105.61% | 3.37M 98.28% | 18.99M 463.72% | 14.41M 24.13% | 6.84M 52.50% | 22.35M 226.61% | 65.35M 192.39% | 32.57M 50.16% | 44.31M 36.06% | |
net current asset value | 103.27M - | 60.92M 41.01% | 26.64M 56.27% | 17.56M 34.08% | 11.74M 33.13% | 8.51M 27.57% | 109.04M 1,182.08% | 81.79M 24.99% | 50.91M 37.76% | 13.65M 73.18% | |
net debt to ebitda | 4.45 - | 0.53 88.06% | 0.61 15.01% | 1.32 115.00% | 0.92 29.82% | 0.70 24.43% | 8.31 1,091.57% | 2.28 72.57% | -6.28 375.28% | 0.10 101.58% | |
net income per share | -583.36 - | -324.85 44.31% | -1.79K 449.55% | -50.47 97.17% | -28.11 44.30% | -27.27 2.99% | -15.72 42.37% | -2.33 85.18% | -6.13 163.08% | -1.64 73.26% | |
operating cash flow per share | -528.90 - | -297.10 43.83% | -1.72K 478.09% | -57.49 96.65% | -23.77 58.65% | -21.14 11.08% | -10.48 50.42% | -1.95 81.38% | -1.99 1.99% | -1.61 19.31% | |
payables turnover | 0.39 - | ||||||||||
receivables turnover | 1.09 - | ||||||||||
research and ddevelopement to revenue | 51.09 - | ||||||||||
return on tangible assets | -0.22 - | -0.66 206.78% | -1.28 92.29% | -0.69 45.95% | -0.93 34.58% | -1.64 76.27% | -0.20 87.99% | -0.39 96.28% | -1.45 275.78% | -0.32 77.89% | |
revenue per share | 0.08 - | ||||||||||
roe | -0.23 - | -0.73 224.53% | -1.41 93.48% | -0.67 52.29% | -0.97 43.94% | -1.89 94.62% | -0.12 93.66% | -0.21 75.81% | -1.04 394.01% | -0.48 53.49% | |
roic | -0.22 - | -0.73 226.10% | -1.42 93.57% | -0.67 52.48% | -0.97 43.78% | -1.77 82.73% | -0.10 94.64% | -0.21 119.35% | 0.10 147.31% | -0.51 620.23% | |
sales general and administrative to revenue | 83.77 - | ||||||||||
shareholders equity per share | 2.59K - | 444.72 82.84% | 1.26K 184.03% | 74.85 94.07% | 28.97 61.30% | 14.44 50.15% | 131.32 809.47% | 11.07 91.57% | 5.89 46.75% | 3.39 42.50% | |
stock based compensation to revenue | 26.43 - | ||||||||||
tangible asset value | 103.50M - | 61.72M 40.36% | 26.86M 56.49% | 17.59M 34.53% | 12.63M 28.21% | 9.46M 25.03% | 109.56M 1,057.55% | 82.96M 24.28% | 51.80M 37.56% | 83.42M 61.05% | |
tangible book value per share | 2.59K - | 444.72 82.84% | 1.26K 184.03% | 67.67 94.64% | 25.23 62.71% | 14.44 42.78% | 75.49 422.80% | 5.60 92.58% | 3.63 35.23% | 3.39 6.55% | |
working capital | 103.27M - | 61.01M 40.92% | 26.72M 56.20% | 17.56M 34.29% | 11.74M 33.13% | 8.65M 26.34% | 113.15M 1,208.21% | 83.94M 25.81% | 53.04M 36.81% | 52.23M 1.53% |
All numbers in USD (except ratios and percentages)